Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
oleh: Nicole Trepanowski, MD, Rebecca M. Yim, BA, Rachel Wetstone, MPH, Elizabeth MacDonald, BS, Sarah Servattalab, MD, Subin Jacob-George, PA, John E. Harris, MD, PhD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-12-01 |
Deskripsi
Subjek
adverse effect; antibody; BMP6; bone morphogenetic protein 6; Dynein light chain Tctex-type 3; Dynlt3